Copeland Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Copeland Capital Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,660	Closed	-$118K	–	278
2020 Q2	$118K	Sell	2,660 -475,456	-99%	-$17.7M	0.01%	134
2020 Q1	$17.2M	Buy	478,116 +3,136	+0.7%	+$178K	1.04%	35
2019 Q4	$33.7M	Buy	474,980 +89,408	+23%	+$6.49M	1.47%	29
2019 Q3	$28.8M	Buy	385,572 +19,671	+5%	+$1.67M	1.48%	30
2019 Q2	$29.5M	Buy	365,901 +53,894	+17%	+$3.79M	1.64%	23
2019 Q1	$20.9M	Buy	312,007 +54,449	+21%	+$4.12M	1.33%	32
2018 Q4	$19.2M	Buy	257,558 +85,654	+50%	+$7.07M	1.37%	28
2018 Q3	$15.8M	Buy	171,904 +37,179	+28%	+$3.54M	0.96%	44
2018 Q2	$13.3M	Buy	+134,725	New	+$15.1M	0.78%	59

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Copeland Capital Management's CMD Position: Q3 2020 in Review

Copeland Capital Management sold out of Cantel Medical Corporation (CMD) in Q3 2020, closing a stake of 2,660 shares — an estimated $118K sold.

Copeland Capital Management first reported a position in CMD in Q2 2018 and held it in 9 quarters. The position peaked at $33.7M in Q4 2019. 196 funds tracked by Wall St. Rank hold CMD as of Q3 2020.

Copeland Capital Management reported no remaining Cantel Medical Corporation position as of Q3 2020 after selling out during the quarter.
Copeland Capital Management sold 2,660 Cantel Medical Corporation shares in Q3 2020, an estimated $118K.
Copeland Capital Management first reported a position in Cantel Medical Corporation in Q2 2018 and held it in 9 quarters.
Copeland Capital Management's Cantel Medical Corporation position peaked at $33.7M in Q4 2019.
196 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2020.

Based on Copeland Capital Management's 13F filing for Q3 2020, filed 22 Oct 2020.